Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21416470

J Surg Oncol 2011 Jul 1 104 1 29-36

Download in:

View as

General Info

PMID
21416470